MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma

Lancet Respir Med. 2024 Jun;12(6):423-424. doi: 10.1016/S2213-2600(24)00146-2. Epub 2024 May 10.

Authors

Federica Grosso¹, Luigi Cerbone², Alessandra Curioni-Fontecedro³

Affiliations

¹ Mesothelioma and Rare Cancers Unit, Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Electronic address: [email protected].
² Mesothelioma and Rare Cancers Unit, Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
³ Clinic of Oncology, Cantonal Hospital Fribourg, Fribourg, Switzerland; Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.

PMID: 38740043
DOI: 10.1016/S2213-2600(24)00146-2

No abstract available

Publication types

News

MeSH terms

Humans
Lung Neoplasms / surgery
Mesothelioma* / surgery
Mesothelioma, Malignant / surgery
Pleura / surgery
Pleural Neoplasms* / surgery
Randomized Controlled Trials as Topic
Treatment Outcome